Overview

• Fleury disclosed in a CVM-filed statement that discussions with Rede D’Or are ongoing and remain non-binding.
• The filing said there are no commitments or documents in place between the companies regarding a potential transaction.
• Columnist Lauro Jardim reported that Rede D’Or recently paused conversations with Fleury because of a price disagreement, a claim not confirmed by the companies.
• The same column said Rede D’Or opened talks with Alliança and Dasa, while a Dasa board member told the columnist there were no recent negotiations with Rede D’Or.
• Coverage notes Rede D’Or owns the Richet laboratory and is seeking to expand in medical diagnostics, a strategy not formally detailed by the company in these disclosures.